Cecelia Perkins

1.1k total citations
11 papers, 157 citations indexed

About

Cecelia Perkins is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Cecelia Perkins has authored 11 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 4 papers in Hematology and 4 papers in Immunology. Recurrent topics in Cecelia Perkins's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Mast cells and histamine (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Cecelia Perkins is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Mast cells and histamine (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Cecelia Perkins collaborates with scholars based in United States, Austria and Germany. Cecelia Perkins's co-authors include Jason Gotlib, Tracy I. George, Jason D. Merker, Caroline Berube, David Sternberg, Steven Coutré, Jun Ma, C. L. Corless, Bruno C. Medeiros and Daniel J. DeAngelo and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Leukemia.

In The Last Decade

Cecelia Perkins

9 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cecelia Perkins United States 4 93 74 49 37 37 11 157
Juliana Schwaab Germany 6 59 0.6× 37 0.5× 60 1.2× 41 1.1× 59 1.6× 14 141
Sophie Roenneberg Germany 6 127 1.4× 75 1.0× 26 0.5× 20 0.5× 11 0.3× 9 243
Carlos de la Calle‐Fabregat Spain 8 98 1.1× 43 0.6× 13 0.3× 132 3.6× 43 1.2× 10 237
Sophine Boysen Krintel Denmark 5 43 0.5× 78 1.1× 31 0.6× 60 1.6× 19 0.5× 9 162
Paweł Kuś Poland 4 79 0.8× 19 0.3× 80 1.6× 58 1.6× 160 4.3× 6 233
Zonghong Shao China 8 32 0.3× 20 0.3× 60 1.2× 68 1.8× 117 3.2× 29 180
Nemanja Damjanov Serbia 6 74 0.8× 77 1.0× 22 0.4× 75 2.0× 41 1.1× 7 203
Aurélie De Groof Belgium 6 58 0.6× 67 0.9× 10 0.2× 26 0.7× 10 0.3× 7 107
Giuseppe Auteri Italy 7 22 0.2× 33 0.4× 63 1.3× 52 1.4× 87 2.4× 22 143
Nur Hezrin Shahrin Australia 5 32 0.3× 13 0.2× 39 0.8× 52 1.4× 60 1.6× 16 130

Countries citing papers authored by Cecelia Perkins

Since Specialization
Citations

This map shows the geographic impact of Cecelia Perkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecelia Perkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecelia Perkins more than expected).

Fields of papers citing papers by Cecelia Perkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecelia Perkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecelia Perkins. The network helps show where Cecelia Perkins may publish in the future.

Co-authorship network of co-authors of Cecelia Perkins

This figure shows the co-authorship network connecting the top 25 collaborators of Cecelia Perkins. A scholar is included among the top collaborators of Cecelia Perkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecelia Perkins. Cecelia Perkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Reiter, Andreas, Jason Gotlib, Iván Álvarez‐Twöse, et al.. (2025). Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control study. Leukemia Research. 157. 107919–107919.
2.
Shen, Zhu, Cecelia Perkins, Vanita Natu, et al.. (2021). Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms. Cell Reports Medicine. 2(10). 100425–100425. 34 indexed citations
3.
Krishnan, Anandi, Jason Gotlib, Holden T. Maecker, et al.. (2021). 3082 – PLATELET TRANSCRIPTOME YIELDS PROGRESSIVE MARKERS IN CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND IDENTIFIES PUTATIVE TARGETS OF THERAPY. Experimental Hematology. 100. S82–S82. 1 indexed citations
4.
Ronner, Lukas, Nikolai A. Podoltsev, Jason Gotlib, et al.. (2019). Persistent Leukocytosis in Polycythemia Vera Is Associated with Disease Evolution but Not Thrombosis: An Analysis from a 520-Patient Retrospective Multi-Center Database. Blood. 134(Supplement_1). 2949–2949. 2 indexed citations
5.
Gotlib, Jason, John H. Baird, Tracy I. George, et al.. (2019). A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis. Blood Advances. 3(15). 2264–2271. 12 indexed citations
6.
Menghrajani, Kamal, Philip S. Boonstra, Cecelia Perkins, et al.. (2018). Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis. Leukemia & lymphoma. 60(4). 1036–1042. 1 indexed citations
7.
Baird, John H., Srđan Verstovšek, Tracy I. George, et al.. (2017). Phase 2 Study of Brentuximab Vedotin in Patients with Advanced Systemic Mastocytosis. Blood. 130. 2909–2909. 1 indexed citations
8.
DeAngelo, Daniel J., Tracy I. George, Cecelia Perkins, et al.. (2017). Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial. Leukemia. 32(2). 470–478. 93 indexed citations
9.
Boonstra, Philip S., Cecelia Perkins, Krisstina Gowin, et al.. (2014). A New Prognostic Model for Response in Myelofibrosis Patients Treated with JAK2 Inhibitors: A Study from Three US Academic Centers. Blood. 124(21). 1842–1842.
10.
Nguyen, Huong, et al.. (2012). FDA-Approved Ruxolitinib in Patients with Myelofibrosis: the Stanford Experience. Blood. 120(21). 1747–1747. 2 indexed citations
11.
Barat, Lawrence M., et al.. (1996). Causes of Fever in Patients Infected with Human Immunodeficiency Virus Who Were Admitted to Boston City Hospital. Clinical Infectious Diseases. 23(2). 320–328. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juliana Schwaab Breakdown of academic impact, for papers by Sophie Roenneberg Breakdown of academic impact, for papers by Carlos de la Calle‐Fabregat Breakdown of academic impact, for papers by Sophine Boysen Krintel Breakdown of academic impact, for papers by Paweł Kuś Breakdown of academic impact, for papers by Zonghong Shao Breakdown of academic impact, for papers by Nemanja Damjanov Breakdown of academic impact, for papers by Aurélie De Groof Breakdown of academic impact, for papers by Giuseppe Auteri Breakdown of academic impact, for papers by Nur Hezrin Shahrin
Rankless by CCL
2026